Literature DB >> 31469119

Coronary artery ectasia carries a worse prognosis: a long-term follow-up study.

Usama Boles1, Urban Wiklund2, Santhosh David3, Khalid Ahmed3, Michael Y Henein4.   

Abstract

Entities:  

Year:  2019        PMID： 31469119     DOI： 10.20452/pamw.14959

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN： 0032-3772


× No keyword cloud information.
  4 in total

Review 1.  Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Dimitrios Kazantzis; Jorge Sanz-Sánchez; Sotiria G Giotaki; Konstantinos Raisakis; Andreas Kaoukis; Charalampos Kossyvakis; Gerasimos Deftereos; Bernhard Reimers; Dimitrios Avramides; Gerasimos Siasos; Michael Cleman; George Giannopoulos; Alexandra Lansky; Spyridon Deftereos
Journal:  Diagnostics (Basel)       Date:  2022-04-19

Review 2.  Coronary Artery Ectasia: Review of the Non-Atherosclerotic Molecular and Pathophysiologic Concepts.

Authors:  Gavin H C Richards; Kathryn L Hong; Michael Y Henein; Colm Hanratty; Usama Boles
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

3.  Long-Term Prognosis in Young Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention.

Authors:  Oren Yagel; Naseem Shadafny; Gabby Elbaz Greener; Ronny Alcalai; Ran Eliaz; Gil Dagan; David Leibowitz; Ilgar Tahiroglu; David Planer; Offer Amir
Journal:  Vasc Health Risk Manag       Date:  2021-04-19

4.  Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups.

Authors:  Cheng-Hui Fan; Ying Hao; Yong-Hua Liu; Xiao-Lin Li; Zhen-Hao Huang; Yu Luo; Rui-Lin Li
Journal:  BMC Cardiovasc Disord       Date:  2020-07-11       Impact factor: 2.298
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.